Legal Representation
Attorney
Syed Abedi
USPTO Deadlines
Next Deadline
128 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
November 21, 2025
Extension Available
Until May 21, 2025
Application History
29 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 28, 2025 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Apr 4, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 4, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 3, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 3, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Dec 14, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 14, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 9, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 12, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 12, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 21, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 26, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 26, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 6, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 6, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 16, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 16, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 16, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 16, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 16, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Feb 13, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 13, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 13, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 1, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 1, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 1, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 30, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 4, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 8, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Clinical preparations in the nature of chemical, biological, and cellular preparations for use in cell and gene therapy research; Clinical preparations in the nature of chemical, biological, and cellular preparations for use in the field of scientific research and the treatment of cancer, autoimmune diseases and other infectious and immune-related diseases
Class 005
Pharmaceutical and medical preparations in the nature of medical preparations for the treatment of cancer, autoimmune diseases and other infectious and immune-related diseases; Pharmaceutical and medical preparations for use in treatment of cancer, autoimmune diseases and other infectious and immune-related diseases; Pharmaceutical and medical preparations for use in cell and gene therapy
Class 042
Scientific and medical research services in the field of cell and gene therapies; Scientific and medical research services for the treatment of cancer, autoimmune diseases and other infectious and immune-related diseases
Class 044
Medical services in the field of cell and gene therapies; Medical services for the treatment of cancer, autoimmune diseases and other infectious and immune-related diseases
Classification
International Classes
001
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIO"